Hansa Biopharma AB (HNSA.ST) Q2 2026 Earnings

23AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-2.59
-2.2
-1.8
-1.41

Details

Expected EPS
-1.412168700549516
Actual EPS
-1.87929918564
Surprise EPS
-0.47
Surprise Percent
+33.08%

Description

Hansa Biopharma AB (HNSA.ST) has reported earnings of -1.87929918564 per share for Q2 2026.

0 Comments

Share your thoughts